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Hepatitis B virus (HBV) is a hepatotropic virus causing acute and chronic hepatitis. It 
consists of a partially double-stranded circular DNA genome which, upon entry into the 
nucleus of hepatocyte, gets converted into an episomal covalently closed circular (ccc) DNA 
(1). The cccDNA minichromosome serves as a template for transcription of all the four viral 
mRNAs by length, which are translated into seven proteins. One baffling small regulatory 
HBV protein is the X protein (HBx). Because of its pleiotropic functions as a viral 
transactivator, HBx has been a point of interest in the field for long. HBx has been reported 
to play an important role in regulating cccDNA function but the mechanism remains 
obscure. One of the best documented interactions of HBx with a host factor is with the 
DNA-damage binding protein 1 (DDB1) (2). However, the link between the HBx-DDB1 
nexus and cccDNA regulation has yet to be established. Recently, Decorsière et al uncovered 
an intriguing finding showing that HBx enhances cccDNA transcription by promoting the 
degradation of a host factor, the structural maintenance of chromosomes (Smc)5/6 complex, 
through DDB1-associated ubiquitin-proteasome system (Fig.1) (3). [Decorsiere A, et al. 
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. Nature 
2016; 531: 386-389.]
In the Ubiquitin-proteasome system, the E3-Ub ligase provides substrate specificity and 
catalyzes ubiquitination of the lysines on the protein substrate for proteasomal degradation. 
Cullin-Ring E3 ligase complex 4A (CRL4) consists of CUL4 as the E3 ubiquitin ligase that 
has been shown to interact with HBx via the adaptor protein DDB1. CUL4-DDB1 have been 
known to target several viral gene products, suggesting an important involvement of the 
ubiquitin-proteasome system in virus maintenance within the cell. In this paper, Decorsière 
et al set out to identify the host target protein that is being degraded by CUL4-DDB1-HBx 
complex.
By fusing TAP-tagged HBx to wild-type DDB1 or mutant DDB1 (binding site for E3-ligase 
complex mutated and hence, no ubiquitination) and using tandem affinity purification and 
co-immunoprecipitation strategies, they were able to recover all the subunits of Smc5/6 
complex in the presence of the mutant DDB1, suggesting that the interaction of HBx to 
DDB1 stabilizes the complex and allows it to interact with the target proteins, Smc5/6 
complex (consisting of Smc5, Smc6 and Nse1-4 subunits). By transfecting a plasmid with 
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luciferase reporter gene driven by HBV enhancer I, they showed increased reporter activity 
and reduced Smc5/6 protein levels in the presence of HBx. Also, they could pull down 
Smc5/6 complex with the transfected reporter plasmids or HBV episomal DNA but not with 
the chromosomally integrated ones and the binding was reduced in the presence of HBx. 
Thus, Decorsière et al concluded that Smc5/6 is a host antiviral factor that associates with 
cccDNA and inhibits its transcription. However, HBx can target Smc5/6 complex for 
degradation through ubiquitination to promote cccDNA transcription.
Smc complexes manage multiple chromosomal activities (4). Literature shows the 
involvement of Smc5/6 complex in many homologous recombination events including DNA 
repair and sister chromatid recombination; replication in normal and rDNA containing 
chromosome and in chromosome topology. SUMOylation by Nse2 subunit has been one of 
the reported mechanisms. However, researchers in this field strongly believe that there is 
more to the story about Smc’s physiological role and this paper adds by identifying Smc5/6 
complex as a host antiviral transcriptional repressor.
One of the many merits of this paper was the use of in vitro and in vivo HBV infection 
systems to express HBx at its physiological level (in the context of HBV replication), 
thereby reducing the possibility of artifacts caused by overexpression, though showing 
Western blots or other direct measurements of HBx under these conditions would have 
completed the picture. Furthermore, the utilization of chronic hepatitis B patient liver 
samples to experiment the phenomena of HBx-mediated degradation of Smc5/6 would have 
strongly reinforced the conclusions made in the paper and made it a more plausible target for 
therapeutic interventions.
Decorsière et al reiterates a previous study that HBx is an immediate early gene for initial 
HBV infection and required to be present all the time for virus persistence (5). The 
conclusion by Lucifora et al that HBx is not required by the virus to enter the host cell but is 
essential for HBV cccDNA transcription is seconded by Decorsière et al. In fact, Lucifora et 
al also showed that HBx is needed for viral transcription from cccDNA but not the 
integrated HBV genome, which is supported to some extent by Decorsière et al while stating 
that HBx relieves Smc-mediated transcriptional repression exclusively on an episomal 
genome. However, the above statement contradicts a number of previous studies with 
demonstrated stimulation of host chromosome transcription by HBx. For example, Xu et al 
reported that the transcomplementation of HBx could enhance the X-minus HBV transgene 
transcription in transgenic mice (6), which argues against the episome-specific 
transactivation effect of HBx. This paradox awaits further investigations.
Based on the conclusions of the paper it seems that, in the absence of HBx, Smc complex 
specifically silences the transcription from episomal viral or plasmid DNA, but not the 
integrated gene. However, there is lack of proper comparisons between episomal and non-
episomal DNA binding by Smc5/6 in the same cells. Furthermore, there is a need to 
elucidate the mechanism that makes this Smc-mediated transcriptional suppression specific 
to episomal DNA.
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Another important question that comes around as a follow up is the mechanism behind the 
silencing effect of Smc5/6 complex on cccDNA transcription and what enables X mRNA 
still to be transcribed once Smc5/6 is already loaded on cccDNA to repress the same. One 
plausible explanation is that the binding of Smc complex to cccDNA minichromosome 
causes chromatin remodeling or epigenetic modifications and subsequently inhibits the 
binding of host RNA polymerase II to the viral promoters except for X promoter. Mapping 
the binding sites of Smc complex on cccDNA would help to answer the question.
Many avihepadnaviruses do not encode X gene. Thus, the mechanism for their cccDNA 
transcription regulation is the next important question that needs to be answered. Smc5/6 
homologs have been predicted to exist in all living microorganisms, from bacteria to humans 
including birds (4). Hence, do these avian homologs resemble in function as the mammalian 
Smc complex and if so, then what is the protein that makes up for X’s function in 
avihepadnaviruses? A possible explanation would be the presence of an entirely different 
mechanism for the regulation or use of a viral protein other than X to target Smc complex’s 
inhibition. Another possibility is the presence of a conserved X-like protein in 
avihepadnaviruses helping in the repression of the Smc5/6 complex-induced silencing of 
cccDNA transcription. In line with this, earlier studies have predicted an X-like protein 
encoding ORF (with or without canonical start codon) in avian viruses at the position similar 
to that of X gene of orthohepadnaviruses (7, 8).
This paper may also excite scientists’ interest in assessing the potential involvement of Smc 
complex in the transcriptional regulation of other viruses with episomal DNA, such as 
papillomaviruses, polyomaviruses, herpesviruses and many more, especially those with 
circular nuclear DNA genomes. While most of these viruses have a replicating episomal 
DNA, HBV cccDNA minichromosome doesn’t replicate and hence this might determine the 
effect of Smc on transcription from different viruses. Interestingly, many DNA viruses have 
episomal latency, and thus the possible involvement of Smc complex in maintaining the viral 
latency may be another area for investigation.
In summary, the discovery reported by Decorsière and colleagues (Fig 1.) adds another new 
but not the final chapter to the enigmatic story of HBx. It might have unlocked another 
mysterious door to a better understanding of host-virus interactions and a probable futuristic 
therapeutic prospect with a lot more yet to unearth.
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Figure 1. Schematic representations of HBx-mediated HBV cccDNA transcription via 
degradation of Smc5/6 complex
(A) Shows the initial binding of SMC5/6 complex with cccDNA blocks major HBV mRNA 
transcription (precore mRNA, pregenomic RNA, and surface mRNAs) but not HBx mRNA 
transcription and protein expression. (B) Shows the initially expressed HBx binds to the 
DDB1-CUL4 complex in the cytoplasm. The entire HBx-DDB1-CUL4 complex is then 
transported to the nucleus and targets cccDNA-bound SMC5/6 complex for ubiquitin-
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dependent proteosomal degradation, by which relieves the transcription repression on 
cccDNA and allows entire viral gene expression.
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